Rui Avelar, M.D., is a distinguished medical professional who currently holds the position of Chief Medical Officer and Head of Research and Development at EVOLUS INC. Dr. Avelar brings a wealth of experience and expertise to his role, having dedicated his career to advancing the field of medical aesthetics and therapeutics. Prior to joining EVOLUS, he held significant leadership positions at Allergan, where he played a pivotal role in the development and commercialization of several successful products, including BOTOX® Cosmetic and JUVÉDERM®. At EVOLUS, Dr. Avelar oversees the company's research and development efforts, focusing on innovative solutions in the aesthetic medicine space. His leadership has been instrumental in the successful launch and growth of Jeuveau®, EVOLUS' flagship neurotoxin product. Under his guidance, the company has expanded its product portfolio and strengthened its position in the competitive aesthetics market. Dr. Avelar's strategic vision and commitment to scientific excellence have been key drivers in EVOLUS' mission to deliver high-quality, patient-centric solutions. In addition to his corporate responsibilities, Dr. Avelar is an active member of the medical community, regularly contributing to scientific literature and participating in industry conferences. His dedication to advancing the field of aesthetic medicine is evident in his numerous publications and presentations, which have helped shape the industry's understanding of neurotoxin treatments and their applications. Dr. Avelar's leadership at EVOLUS not only drives the company's success but also contributes to the broader advancement of medical aesthetics, making him a respected figure in the industry.